Results summary | View all lists in L2L MDB | View all genes in A01AC.profile.ud50 |
Down-regulated at least 1.4-fold following treatment of HepG2 human hepatocellular carcinoma cells with carcinogen benzo(a)pyrene (BaP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. enrichment: 7.22-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
209833_AT | CRADD | G | P | S | CASP2 and RIPK1 domain containing adaptor with death domain | ||||||||
201108_S_AT | THBS1 | D | X | C | thrombospondin 1 |